<DOC>
	<DOCNO>NCT00427232</DOCNO>
	<brief_summary>Endothelin hormon cause acute chronic narrow heart vessel . The purpose study ass whether suppression activity use two type receptor antagonist reduce effect thus improve blood supply heart muscle .</brief_summary>
	<brief_title>Endothelin-Receptor Blockade Coronary Heart Disease</brief_title>
	<detailed_description>Endothelin ( ET ) potent vasoconstrictor know play major role development coronary artery disease well acute vasoconstriction . This effect mainly mediate vascular ET-A receptor , whereas ET-B receptor mediate vasodilation cleavage ET . Currently , selective ET-A antagonist non-selective ET-A ET-B antagonist investigation . The aim study test effect ET-receptor blockade vasoreagibility epicardial intramyocardial coronary artery patient undergo cardiac catheterization . We randomly use selective ET-A receptor BQ-123 ( Group A ) combination BQ-123 ET-B receptor antagonist BQ-788 ( Group B ) . The tested infusion apply selectively assessed coronary artery special infusion catheter . To evaluate morphometric change use quantitative coronary angiography measure diameter coronary artery intracoronary infusion test substance . Furthermore use Pressure Wire measure hemodynamic condition infusion , thus evaluate epicardial intramyocardial blood perfusion . Comparison : Coronary artery diameter measure quantitative angiography ( minimal lumen diameter ) parameter indicative epicardial intramyocardial blood flow determine Pressure Wire ( fractional flow reserver , coronary flow reserve , intramyocardial resistance ) ET-antagonist infusion compare .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>coronary artey disease stable angina pectoris male postmenopausal female patient age 19 year able willing conform requirement study provide write informed consent severe focal coronary stenosis visually calcify stenosis aortoostial lesion location unprotected leave main stenosis premenopausal female patient diabetes mellitus unstable angina pectoris and/or acute Qwave myocardial infarctaion within past 72 hour current vasoactive medication previous percutaneous transluminal revascularization site target lesion lesion extremely angulated segment &gt; 90 % vessel escessive tortuosity proximal segment severe hypotension severely reduce left ventricular function severe carotid stenosis patient pace maker patient elevate liver enzyme patient simultaneously participate another device drug study inability unwillingness comply study protocol</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>coronary heart disease</keyword>
	<keyword>endothelins</keyword>
	<keyword>coronary angiography</keyword>
	<keyword>blood flow velocity</keyword>
	<keyword>fractional flow reserve , myocardial</keyword>
</DOC>